Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monique Hinchcliff

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Rheumatology (Oxford, England)|June 25, 2022
A genomic meta-analysis of clinical variables and their association with intrinsic molecular subsets in systemic sclerosisJennifer M Franks, Diana M Toledo, Viktor Martyanov, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2011
Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polypsBruce K Tan, Quan-Zhen Li, Lydia Suh, et al.
Journal of Scleroderma and Related Disorders|June 28, 2021
Mast Cell Activation in the Systemic Sclerosis EsophagusKevin Tom, Bhaven K Mehta, Aileen Hoffmann, et al.
Arthritis Research & Therapy|July 30, 2015
Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signaturesJaclyn N Taroni, Viktor Martyanov, Chiang-Ching Huang, et al.
JCI Insight|December 27, 2016
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severityShane Lofgren, Monique Hinchcliff, Mary Carns, et al.
Rheumatology Advances in Practice|November 3, 2025
Insight from convergent validity of assessment of systemic sclerosis-associated Raynaud phenomenon with nailfold capillaroscopyKrishnasai Abhishek Madathanapalli, Areeka Memon, Manvitha Nadella, et al.
Arthritis Research & Therapy|June 15, 2021
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohortSara Jaafar, Alain Lescoat, Suiyuan Huang, et al.
The Journal of Investigative Dermatology|February 3, 2018
Mycophenolate Mofetil Treatment of Systemic Sclerosis Reduces Myeloid Cell Numbers and Attenuates the Inflammatory Gene Signature in SkinMonique Hinchcliff, Diana M Toledo, Jaclyn N Taroni, et al.
Arthritis Research & Therapy|April 11, 2025
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosisIlayda Gunes, Elana J Bernstein, Shawn E Cowper, et al.
Research Square|November 1, 2024
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosisIlayda Gunes, Elana Bernstein, Shawn E Cowper, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Rheumatology (Oxford, England)|June 25, 2022
A genomic meta-analysis of clinical variables and their association with intrinsic molecular subsets in systemic sclerosisJennifer M Franks, Diana M Toledo, Viktor Martyanov, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2011
Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polypsBruce K Tan, Quan-Zhen Li, Lydia Suh, et al.
Journal of Scleroderma and Related Disorders|June 28, 2021
Mast Cell Activation in the Systemic Sclerosis EsophagusKevin Tom, Bhaven K Mehta, Aileen Hoffmann, et al.
Arthritis Research & Therapy|July 30, 2015
Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signaturesJaclyn N Taroni, Viktor Martyanov, Chiang-Ching Huang, et al.
JCI Insight|December 27, 2016
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severityShane Lofgren, Monique Hinchcliff, Mary Carns, et al.
Rheumatology Advances in Practice|November 3, 2025
Insight from convergent validity of assessment of systemic sclerosis-associated Raynaud phenomenon with nailfold capillaroscopyKrishnasai Abhishek Madathanapalli, Areeka Memon, Manvitha Nadella, et al.
Arthritis Research & Therapy|June 15, 2021
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohortSara Jaafar, Alain Lescoat, Suiyuan Huang, et al.
The Journal of Investigative Dermatology|February 3, 2018
Mycophenolate Mofetil Treatment of Systemic Sclerosis Reduces Myeloid Cell Numbers and Attenuates the Inflammatory Gene Signature in SkinMonique Hinchcliff, Diana M Toledo, Jaclyn N Taroni, et al.
Arthritis Research & Therapy|April 11, 2025
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosisIlayda Gunes, Elana J Bernstein, Shawn E Cowper, et al.
Research Square|November 1, 2024
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosisIlayda Gunes, Elana Bernstein, Shawn E Cowper, et al.
Pageof 12